← Back to All US Stocks

BMEZ Stock Analysis - BlackRock Health Sciences Term Trust AI Rating

BMEZ NYSE MD CIK: 0001785971
Recently Updated • Analysis: Mar 21, 2026 • SEC Data: 2026-03-21
AI Rating
HOLD
15% Confidence

📊 BMEZ Key Takeaways

Revenue: N/A
Net Margin: N/A
Free Cash Flow: N/A
Current Ratio: N/A
Debt/Equity: N/A
EPS: $0.00
AI Rating: HOLD with 15% confidence

Investment Thesis

BlackRock Health Sciences Term Trust (BMEZ) is a closed-end fund with insufficient fundamental data available for meaningful analysis. With only 1 metric available and no income statement, balance sheet, or cash flow data, a comprehensive assessment of financial health and performance is impossible. The minimal data quality severely limits the ability to evaluate investment merit based on fundamentals.

BMEZ Strengths

  • + Closed-end fund structure with defined management team (implied by BlackRock branding)
  • + Recent insider activity indicating management engagement (3 Form 4 filings in 90 days)
  • + Focus on healthcare/life sciences sector provides thematic diversification

BMEZ Risks

  • ! Acute lack of financial data - 99% of metrics unavailable for analysis
  • ! Unable to assess fund performance, holdings quality, or distribution sustainability
  • ! No visibility into net asset value, expense ratios, leverage, or portfolio composition
  • ! Cannot evaluate profitability or financial health of underlying portfolio

Key Metrics to Watch

BMEZ Financial Metrics

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

BMEZ Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

BMEZ vs Default Sector

How BlackRock Health Sciences Term Trust compares to Default sector averages

Net Margin
BMEZ 0.0%
vs
Sector Avg 12.0%
BMEZ Sector
ROE
BMEZ 0.0%
vs
Sector Avg 15.0%
BMEZ Sector
Current Ratio
BMEZ 0.0x
vs
Sector Avg 1.8x
BMEZ Sector
Debt/Equity
BMEZ 0.0x
vs
Sector Avg 0.7x
BMEZ Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

BMEZ Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

BMEZ Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

BMEZ SEC Filings

Access official SEC EDGAR filings for BlackRock Health Sciences Term Trust (CIK: 0001785971)

📋 Recent SEC Filings

Date Form Document Action
Feb 3, 2026 4 xslF345X05/ownership.xml View →
Feb 3, 2026 4 xslF345X05/ownership.xml View →
Dec 22, 2025 4 xslF345X05/ownership.xml View →
May 22, 2025 DEF 14A d892899ddef14a.htm View →
Apr 22, 2025 4 xslF345X05/primary_doc.xml View →

Frequently Asked Questions about BMEZ

What is the AI rating for BMEZ?

BlackRock Health Sciences Term Trust (BMEZ) has an AI rating of HOLD with 15% confidence, based on fundamental analysis of SEC EDGAR filings.

What are BMEZ's key strengths?

Closed-end fund structure with defined management team (implied by BlackRock branding). Recent insider activity indicating management engagement (3 Form 4 filings in 90 days).

What are the risks of investing in BMEZ?

Acute lack of financial data - 99% of metrics unavailable for analysis. Unable to assess fund performance, holdings quality, or distribution sustainability.

What is BMEZ's revenue and growth?

BlackRock Health Sciences Term Trust reported revenue of N/A.

Does BMEZ pay dividends?

BlackRock Health Sciences Term Trust does not currently pay dividends.

Where can I find BMEZ SEC filings?

Official SEC filings for BlackRock Health Sciences Term Trust (CIK: 0001785971) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is BMEZ's EPS?

BlackRock Health Sciences Term Trust has a diluted EPS of $0.00.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 21, 2026 | Data as of: 2026-03-21 | Powered by Claude AI